THE AMERICAN CHAMBER OF COMMERCE IN TAIPEI TAIWAN BUSINESS TOPICS August 2020 | Vol. 50 | Issue 8 ADVERTORIAL
Martin Turvill notes that Taiwan's talent pool has served as the backbone of SHL's success.
patients who may be wracked in pain, such as during a migraine attack, or have SHL: Taking the Lead difficulty with manual dexterity, as may occur with rheumatoid arthritis. A further advantage that the in Innovation and autoinjectors bring the patient is added safety, both in terms of protection from Digitalization needle sticking and assurance of proper dosage. ounded in Taiwan in 1989 by means making optimum use of data. As SHL looks to the future, Turvill sees a young Swedish entrepreneur, SHL’s operations have long generated sustainability as the next major area for F Roger Samuelsson, SHL Medical massive amounts of documentation, innovation. “Once an autoinjector is fired, has grown from a small medical-device including data covering design, process, it has to be disposed of, so it clearly has supplier to one of the world’s leading testing, simulation, materials, and other an environmental impact,” he notes. “Our designers and producers of autoinjectors. aspects. This includes analytical details innovation team is looking at how we can Of the company’s approximately 5,000 of its raw materials to the amount of make these items as recyclable as possible. employees globally, 4,600 work at one of force needed to remove the cap from Each one contains glass, metal, plastic, its nine facilities in Taiwan, all of them a device. “The data was there, but it rubber, and a drug, so it’s going to be a located in Taoyuan. was not yet being used in an integrated challenge. But we’re looking very seriously In line with SHL’s dedication to manner that would bring the most value at what can be doable.” constant innovation, the company is to our design and production processes,” To tackle all these challenges, SHL currently in the midst of a two-year says Turvill. “We have begun integrating maintains innovation teams in three program to completely digitalize its all that information and make it easily locations – Taiwan and in its design operations. “Innovation is no longer just accessible throughout the organization” and development centers in Stockholm, about technical advances and designing – for example to the team tasked with Sweden and in Deerfield, Florida in the the latest, newest device,” says SHL designing the next product or even a new U.S. It is also setting up a fourth design Medical Taiwan Managing Director cap for an existing product. “This allows team in Switzerland to further expand its Martin Turvill. “Rather, it’s about our design engineers to make data-driven innovation portfolio. And the innovation everything needed to support that design decisions that are better aligned with the process requires input from a variety of and manufacturing.” Increasingly, that manufacturing teams,” Turvill adds. different disciplines. “What we’re involved Another objective of the innovation in today is more than the basic R&D of drive is to continue to achieve greater five or ten years ago, when it was just product simplicity. Since the purpose of a matter of getting the designers and SHL products is to enable patients to self- engineers together,” says Turvill. “Now administer the medicine they require, the we need to include the data experts and company is highly aware of the need to specialists in statistical analysis, as well make these devices as easy and intuitive as the simulation experts and material to use as possible. In 2006, SHL became experts. Bringing all these functions and one of the world’s first companies to bring disciplines together helps us improve the modern autoinjector to market. Since the quality of our products, making the then, various generations of development innovation of both products and processes have brought the auto-injection process much more meaningful.” down to the two-step approach – just Turvill says SHL has had no difficulty uncap and inject – found in SHL’s Molly® finding the talent it needs in Taiwan family of devices. That convenience and to match its steady expansion and the SHL is a world-leading designer and innovator of development of ever more advanced self-administered autoinjectors. ease-of-use is especially important for
2 TAIWAN BUSINESS TOPICS • AUGUST 2020
SHL.indd 2 2020/8/4 下午10:01 ADVERTORIAL
products. “The skills are here, and we’ve by biologic and biosimilar drugs, which seen the standard of engineering and need to be administered through injection. standard of education getting better and Since these drugs are generally more better over the years.” He notes that two viscous and require higher volumes, SHL decades or so ago, Taiwanese workers has continuously developed new models to were good at following directions but accommodate those specifications. tended to be reluctant to voice their At the same time, autoinjectors have opinions and show initiative. “That’s indirectly contributed to the fight against no longer the case, and Taiwan’s diverse this year’s special circumstances. “When and prolific talent pool have truly been the coronavirus situation happened, the backbone of the company’s success,” many people who previously went to the Turvill says. hospital to get their injection realized it During this year of COVID-19 would be best to avoid taking the bus and pandemic, SHL’s business has continued going to a crowded public place,” Turvill to grow smoothly. In part, that increase says. “Now they’re finding that they can represents an extension of existing trends, do the procedure conveniently from home, especially the steady rise in the amount and that’s something the health authorities Data-driven initiatives enable complete alignment of pharmaceutical sales accounted for are encouraging.” between design and production processes.
瑞健:引領創新, 加速數位轉型